These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


514 related items for PubMed ID: 1384311

  • 1. Immunologic markers of progression to acquired immunodeficiency syndrome are time-dependent and illness-specific.
    Krämer A, Biggar RJ, Hampl H, Friedman RM, Fuchs D, Wachter H, Goedert JJ.
    Am J Epidemiol; 1992 Jul 01; 136(1):71-80. PubMed ID: 1384311
    [Abstract] [Full Text] [Related]

  • 2. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.
    Fahey JL, Taylor JM, Detels R, Hofmann B, Melmed R, Nishanian P, Giorgi JV.
    N Engl J Med; 1990 Jan 18; 322(3):166-72. PubMed ID: 1967191
    [Abstract] [Full Text] [Related]

  • 3. Virologic and serologic markers of rapid progression to AIDS after HIV-1 seroconversion.
    Farzadegan H, Henrard DR, Kleeberger CA, Schrager L, Kirby AJ, Saah AJ, Rinaldo CR, O'Gorman M, Detels R, Taylor E, Phair JP, Margolick JB.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Dec 15; 13(5):448-55. PubMed ID: 8970472
    [Abstract] [Full Text] [Related]

  • 4. Immune activation markers and AIDS prognosis.
    Osmond DH, Shiboski S, Bacchetti P, Winger EE, Moss AR.
    AIDS; 1991 May 15; 5(5):505-11. PubMed ID: 1677808
    [Abstract] [Full Text] [Related]

  • 5. Surrogate markers for survival in patients with AIDS and AIDS related complex treated with zidovudine.
    Jacobson MA, Bacchetti P, Kolokathis A, Chaisson RE, Szabo S, Polsky B, Valainis GT, Mildvan D, Abrams D, Wilber J.
    BMJ; 1991 Jan 12; 302(6768):73-8. PubMed ID: 1671651
    [Abstract] [Full Text] [Related]

  • 6. Relationship and prognostic value of endogenous interferon-alpha, beta 2-microglobulin, and neopterin serum levels in patients with Kaposi sarcoma and AIDS.
    Krown SE, Niedzwiecki D, Bhalla RB, Flomenberg N, Bundow D, Chapman D.
    J Acquir Immune Defic Syndr (1988); 1991 Jan 12; 4(9):871-80. PubMed ID: 1895208
    [Abstract] [Full Text] [Related]

  • 7. Tracking of markers and onset of disease among HIV-1 seroconverters.
    Galai N, Muñoz A, Chen K, Carey VJ, Chmiel J, Zhou SY.
    Stat Med; 1993 Nov 30; 12(22):2133-45. PubMed ID: 7906051
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [ Biological criteria for prediction of the clinical course leading to AIDS].
    Salmon D, Couroucé AM, Doinel C, Fine JM, Kaplan C, Lambin P, Lefrère JJ, Rouger P, Salmon C.
    Rev Fr Transfus Hemobiol; 1990 Dec 30; 33(6):407-14. PubMed ID: 1981002
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I.
    AIDS; 1994 Jul 30; 8(7):911-21. PubMed ID: 7946100
    [Abstract] [Full Text] [Related]

  • 12. Immunologic marker paths for seroconversion: single determinations of immunoglobulin A and beta 2-microglobulin are not adequate to estimate time of HIV infection. Multicohort Analysis Project Workshop. Part II.
    AIDS; 1994 Jul 30; 8(7):923-33. PubMed ID: 7946101
    [Abstract] [Full Text] [Related]

  • 13. Clinical and laboratory predictors of survival in Gambian patients with symptomatic HIV-1 or HIV-2 infection.
    Whittle H, Egboga A, Todd J, Corrah T, Wilkins A, Demba E, Morgan G, Rolfe M, Berry N, Tedder R.
    AIDS; 1992 Jul 30; 6(7):685-9. PubMed ID: 1354448
    [Abstract] [Full Text] [Related]

  • 14. Predictive markers for the acquired immunodeficiency syndrome (AIDS) in hemophiliacs: persistence of p24 antigen and low T4 cell count.
    Eyster ME, Ballard JO, Gail MH, Drummond JE, Goedert JJ.
    Ann Intern Med; 1989 Jun 15; 110(12):963-9. PubMed ID: 2567142
    [Abstract] [Full Text] [Related]

  • 15. Early levels of CD4, neopterin, and beta 2-microglobulin indicate future disease progression.
    Shi M, Taylor JM, Fahey JL, Hoover DR, Muñoz A, Kingsley LA.
    J Clin Immunol; 1997 Jan 15; 17(1):43-52. PubMed ID: 9049785
    [Abstract] [Full Text] [Related]

  • 16. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion.
    Mellors JW, Kingsley LA, Rinaldo CR, Todd JA, Hoo BS, Kokka RP, Gupta P.
    Ann Intern Med; 1995 Apr 15; 122(8):573-9. PubMed ID: 7887550
    [Abstract] [Full Text] [Related]

  • 17. The predictive value of several markers in the progression to acquired immunodeficiency syndrome.
    Planella T, Cortés M, Martínez-Brú C, Barrio J, Sambeat MA, González-Sastre F.
    Clin Chem Lab Med; 1998 Mar 15; 36(3):169-73. PubMed ID: 9589805
    [Abstract] [Full Text] [Related]

  • 18. [Lymphocyte subpopulations, neopterin, and beta-2-microglobulin: relationship with clinical stage, risk of progression to AIDS and presence of active infection in HIV infection].
    Antón F, Labarga P, Pinilla J, Soto MJ, Leoz A, del Cura J, Borque L, Milazzo A.
    Enferm Infecc Microbiol Clin; 1993 Mar 15; 11(7):373-7. PubMed ID: 8104488
    [Abstract] [Full Text] [Related]

  • 19. Correlation between surrogate markers, viral load, and disease progression in HIV-1 infection.
    Lafeuillade A, Tamalet C, Pellegrino P, de Micco P, Vignoli C, Quilichini R.
    J Acquir Immune Defic Syndr (1988); 1994 Oct 15; 7(10):1028-33. PubMed ID: 7916049
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 26.